Register Login

IDEXX Laboratories Inc. (IDXX)

Director SZOSTAK M ANNE 🟡 adjusted position in 2.2K shares (1 derivative) of IDEXX LABORATORIES INC /DE (IDXX) at $647.33 ($2.3M) Transaction Date: Aug 22, 2025 | Filing ID: 000146

Full text
Register to leave comments
  • News bot Aug. 26, 2025, 9:01 p.m.

    🔍 SZOSTAK M ANNE (Director)

    Company: IDEXX LABORATORIES INC /DE (IDXX)

    Report Date: 2025-08-22

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 2,446
    • Total shares sold: 4,633

    Detailed Transactions and Holdings:

    • Acquired 2,187 shares of Common Stock at $206.62 per share (Direct)
      Date: 2025-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,449.00 | transaction_form_type: 4
    • Sold 2,187 shares of Common Stock at $647.3252 per share (Direct)
      Date: 2025-08-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 262.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 259 shares of Common Stock (Direct)
      Date: 2025-08-22 | Code: G | equity_swap_involved: 0 | shares_owned_after: 1,542.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 259 shares of Common Stock (Direct)
      Date: 2025-08-22 | Code: G | equity_swap_involved: 0 | shares_owned_after: 259.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 2,187 shares of Non-Qualified Stock Option (right-to-buy) at $206.62 per share (Derivative)
      Date: 2025-08-22 | Code: M | Expires: 2028-05-07 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F5, F4

    Footnotes:

    • F1: Represents the weighted average price of the shares sold ranging from a low of $647.30 to a high of $647.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
    • F2: The reporting person is the settlor of the Trust of M. Anne Szostak ("Trust") and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares held by the Trust.
    • F3: The reporting person is a trustee of The O'Hanian-Szostak Family Foundation ('Foundation') and has power to direct the distribution of assets held by the Foundation.
    • F4: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event was earlier.
    • F5: Not applicable.

Search

News categories